Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy
Clinical trial NCT00270127 · COMPLETED
Trial details
- NCT number
- NCT00270127
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1996-08-01
- Enrollment
- 375
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.